Preparing for widespread use of biomarkers to diagnose Alzheimer’s disease

Chronic conditions in typical patients presenting with cognitive impairment. Credit: Nature Reviews Neurology (2024). DOI: 10.1038/s41582-024-00989-1 For years, many people with Alzheimer’s disease have been diagnosed clinically and confirmed at

Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder

Riluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in

Towards gene-targeting drugs capable of targeting brain diseases

Getting therapeutic drugs past the blood-brain barrier has long been one of medicine’s most difficult challenges, limiting our ability to treat conditions like Alzheimer’s disease, Parkinson’s disease, and brain cancers.